Itau Unibanco Holding S.A.’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $68.3K | Sell |
130
-13
| -9% | -$6.83K | ﹤0.01% | 222 |
|
2025
Q1 | $91K | Sell |
143
-10
| -7% | -$6.36K | ﹤0.01% | 189 |
|
2024
Q4 | $109K | Buy |
153
+67
| +78% | +$47.7K | ﹤0.01% | 195 |
|
2024
Q3 | $90.4K | Buy |
86
+46
| +115% | +$48.4K | ﹤0.01% | 148 |
|
2024
Q2 | $42K | Buy |
+40
| New | +$42K | ﹤0.01% | 175 |
|
2024
Q1 | – | Sell |
-144
| Closed | -$126K | – | 297 |
|
2023
Q4 | $126K | Sell |
144
-98
| -40% | -$86.1K | ﹤0.01% | 168 |
|
2023
Q3 | $199K | Buy |
242
+18
| +8% | +$14.8K | 0.01% | 150 |
|
2023
Q2 | $161K | Buy |
224
+144
| +180% | +$103K | 0.01% | 185 |
|
2023
Q1 | $65.7K | Sell |
80
-319
| -80% | -$262K | ﹤0.01% | 313 |
|
2022
Q4 | $288K | Sell |
399
-73
| -15% | -$52.7K | 0.01% | 175 |
|
2022
Q3 | $325K | Buy |
472
+341
| +260% | +$235K | 0.01% | 178 |
|
2022
Q2 | $77K | Sell |
131
-347
| -73% | -$204K | ﹤0.01% | 301 |
|
2022
Q1 | $334K | Buy |
478
+361
| +309% | +$252K | 0.01% | 170 |
|
2021
Q4 | $75K | Sell |
117
-440
| -79% | -$282K | ﹤0.01% | 236 |
|
2021
Q3 | $337K | Buy |
557
+303
| +119% | +$183K | 0.02% | 129 |
|
2021
Q2 | $142K | Buy |
+254
| New | +$142K | 0.01% | 125 |
|
2019
Q2 | – | Sell |
-71
| Closed | -$26K | – | 767 |
|
2019
Q1 | $26K | Hold |
71
| – | – | ﹤0.01% | 551 |
|
2018
Q4 | $26K | Sell |
71
-12
| -14% | -$4.39K | ﹤0.01% | 551 |
|
2018
Q3 | $34K | Sell |
83
-411
| -83% | -$168K | ﹤0.01% | 557 |
|
2018
Q2 | $170K | Sell |
494
-112
| -18% | -$38.5K | 0.02% | 357 |
|
2018
Q1 | $209K | Buy |
606
+572
| +1,682% | +$197K | ﹤0.01% | 368 |
|
2017
Q4 | $13K | Buy |
34
+2
| +6% | +$765 | ﹤0.01% | 515 |
|
2017
Q3 | $45K | Sell |
32
-91
| -74% | -$128K | ﹤0.01% | 589 |
|
2017
Q2 | $60K | Buy |
123
+112
| +1,018% | +$54.6K | 0.01% | 269 |
|
2017
Q1 | $4K | Buy |
+11
| New | +$4K | ﹤0.01% | 655 |
|